224 related articles for article (PubMed ID: 10524470)
1. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.
Hale ME; Fleischmann R; Salzman R; Wild J; Iwan T; Swanton RE; Kaiko RF; Lacouture PG
Clin J Pain; 1999 Sep; 15(3):179-83. PubMed ID: 10524470
[TBL] [Abstract][Full Text] [Related]
2. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial.
Caldwell JR; Hale ME; Boyd RE; Hague JM; Iwan T; Shi M; Lacouture PG
J Rheumatol; 1999 Apr; 26(4):862-9. PubMed ID: 10229408
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Hale M; Tudor IC; Khanna S; Thipphawong J
Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
[TBL] [Abstract][Full Text] [Related]
4. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
Kopecky EA; Vaughn B; Lagasse S; O'Connor M
Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
Hale ME; Dvergsten C; Gimbel J
J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
[TBL] [Abstract][Full Text] [Related]
6. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.
Roth SH; Fleischmann RM; Burch FX; Dietz F; Bockow B; Rapoport RJ; Rutstein J; Lacouture PG
Arch Intern Med; 2000 Mar; 160(6):853-60. PubMed ID: 10737286
[TBL] [Abstract][Full Text] [Related]
7. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
Kaplan R; Parris WC; Citron ML; Zhukovsky D; Reder RF; Buckley BJ; Kaiko RF
J Clin Oncol; 1998 Oct; 16(10):3230-7. PubMed ID: 9779696
[TBL] [Abstract][Full Text] [Related]
8. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?
Salzman RT; Roberts MS; Wild J; Fabian C; Reder RF; Goldenheim PD
J Pain Symptom Manage; 1999 Oct; 18(4):271-9. PubMed ID: 10534967
[TBL] [Abstract][Full Text] [Related]
9. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
[TBL] [Abstract][Full Text] [Related]
10. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C
Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422
[TBL] [Abstract][Full Text] [Related]
11. The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study.
Parris WC; Johnson BW; Croghan MK; Moore MR; Khojasteh A; Reder RF; Kaiko RF; Buckley BJ
J Pain Symptom Manage; 1998 Oct; 16(4):205-11. PubMed ID: 9803047
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients.
Stambaugh JE; Reder RF; Stambaugh MD; Stambaugh H; Davis M
J Clin Pharmacol; 2001 May; 41(5):500-6. PubMed ID: 11361046
[TBL] [Abstract][Full Text] [Related]
14. Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial.
Leng X; Zhang F; Yao S; Weng X; Lu K; Chen G; Huang M; Huang Y; Zeng X; Hopp M; Lu G
Adv Ther; 2020 Mar; 37(3):1188-1202. PubMed ID: 32020565
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain.
Vorsanger G; Xiang J; Okamoto A; Upmalis D; Moskovitz B
J Opioid Manag; 2010; 6(3):169-79. PubMed ID: 20642246
[TBL] [Abstract][Full Text] [Related]
16. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.
Gimbel JS; Richards P; Portenoy RK
Neurology; 2003 Mar; 60(6):927-34. PubMed ID: 12654955
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients.
Inoue S; Saito Y; Tsuneto S; Aruga E; Takahashi H; Uemori M
Jpn J Clin Oncol; 2018 Jun; 48(6):542-547. PubMed ID: 29659913
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
Nicholson B; Ross E; Sasaki J; Weil A
Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
[TBL] [Abstract][Full Text] [Related]
19. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.
Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Ghalie R; Negro-Vilar A; de Jong E; Gershon S
J Opioid Manag; 2006; 2(6):325-8, 331-3. PubMed ID: 17326594
[TBL] [Abstract][Full Text] [Related]
20. Controlled-release oxycodone and morphine in cancer related pain.
Heiskanen T; Kalso E
Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
